| 标题 |
Effects of dapagliflozin on major adverse kidney and cardiovascular events in patients with diabetic and non-diabetic chronic kidney disease: a prespecified analysis from the DAPA-CKD trial |
| 网址 | |
| DOI | |
| 其它 |
期刊:The Lancet Diabetes & Endocrinology 作者:David C. Wheeler; Bergur V. Stefánsson; Niels Jongs; Glenn M. Chertow; Tom Greene; et al 出版日期:2020-12-17 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)